Inquiries Lampard Inquiry Hearings ongoing Core Participants · Terminology

Hearing Day 54 – July Hearing (2026)

← Day 53 Day 55 →

Tuesday 21 July 2026 · Transcript PDF · Video · Inquiry website

Hearing-day outline

what the day covered
Themes covered
Observations and the use of technology
Gave evidence
Next: Jill Archibald, a nursing expert, will give evidence on the use of observations and technology tomorrow at 10.00 am.
For what was said, read the full transcript →

Documents for this day

FINAL Oxevision Comparator Trust Evidence Paper - 10 July 2026
Hearing Day 54 – Evidence
Hearing Day 54 – Evidence
LPT022545_NP11 LPT Business Case for Oxevision
LPT022550_NP06e LPT Oxehealth Stopped rooms report
LPT022551_NP07 LPT OxeVision Patient Consent Form
LPT022552_NP09 LPT Oxevision - Ashby Ward Pilot Evaluation Report
LPT022553_NP10 LPT Oxevision Ashby Ward Pilot Cost Benefit Analysis
LPT022555_NP08 LPT Board Meeting Paper_ Re Oxehealth - Learning from …
LPT022556_NP06a Oxehealth Weekly Usage Report Re LPT
LPT022557_NP06d Oxehealth Weekly Usage Report Re LPT
LPT022558_NP06b Oxehealth Weekly Usage Report Re LPT
LPT022559_NP06c Oxehealth Weekly Usage Report Re LPT
LPT022560_NP05 LPT DPIA template
LPT022561_NP04 LPT Oxevison Pilot Quick Reference Guide
LPT022562_NP03 LPT Standard Operating Procedure for the use of Oxevis…
LPT022563_NP01a LPT Oxevision Patient Poster
LPT022564_NP02 LPT Easy Read Oxevision Poster
LPT022565_NP01b LPT Oxevision Leaflet
TEWV021312_BM9 Oxevision poster at TEWV
TEWV021313_BM7 TEWV Oxehealth Procedure
TEWV021314_BM8 TEWV Leaflets detailing Oxevision use_ given to patien…
TEWV021315_BM4 TEWV Oxevision Leaflets detailing information provided…
TEWV021316_TBM6 TEWV Oxehealth Policy
TEWV021317_BM3 TEWV Leaflet detailing Oxevision use
TEWV021319_BM22 Oxehealth Stopped Rooms Report ReTEWV
TEWV021320_BM21 TEWV Privacy Notice
TEWV021321_BM20 Oxevision Monthly Usage Report June -December 2024
TEWV021322_BM17 Data Protection Impact Assessment - for Sleep Module
TEWV021324_BM19 TEWV Service Level Agreement with Oxehealth
TEWV021325_BM16 TEWV Data Protection Impact Assessment (DPIA) for Oxe…
TEWV021327_BM15 TEWV Terms of Reference for the Trust’s Oxehealth Gov…
TEWV021329_BM14 TEWV Service Evaluation Report of Staff_ Patients and…
TEWV021330_BM10 TEWV Report_ Re Oxehealth _Digital Care Assistant_ tr…
TEWV021332_BM12 TEWV Early Insights Report containing early insights …
TEWV024265_BM13 TEWV Quantitative impact of Oxevision
Transcript of Hearing
LPT023355_Witness Statement of Andres Freire-Patino
TEWV024264_Witness Statement of Beverley Murphy
TEWV025661_First Witness Statement of Elspeth Devanney_ Director of N…